Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
Molecular Biosystems|October 30, 2010
Synthetic lethal hubs associated with vincristine resistant neuroblastomaRaul Fechete, Susanne Barth, Tsviya Olender, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 15, 2014
A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3Mircea Gabriel Stoleriu, Volker Steger, Migdat Mustafi, et al.
Molecular Pharmacology|February 24, 2004
Valproic acid inhibits angiogenesis in vitro and in vivoMartin Michaelis, U Ruth Michaelis, Ingrid Fleming, et al.
Cells|February 28, 2020
Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to CisplatinShahana Dilruba, Alessia Grondana, Anke C Schiedel, et al.
Cancers|March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell LinesMartin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
International Journal of Molecular Sciences|November 9, 2018
A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage FormationYunyun Luo, Yi He, Ditte Reker, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
International Journal for Parasitology|December 2, 2017
A cell culture platform for Cryptosporidium that enables long-term cultivation and new tools for the systematic investigation of its biologyChristopher N Miller, Lyne Jossé, Ian Brown, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
Molecular Biosystems|October 30, 2010
Synthetic lethal hubs associated with vincristine resistant neuroblastomaRaul Fechete, Susanne Barth, Tsviya Olender, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 15, 2014
A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3Mircea Gabriel Stoleriu, Volker Steger, Migdat Mustafi, et al.
Molecular Pharmacology|February 24, 2004
Valproic acid inhibits angiogenesis in vitro and in vivoMartin Michaelis, U Ruth Michaelis, Ingrid Fleming, et al.
Cells|February 28, 2020
Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to CisplatinShahana Dilruba, Alessia Grondana, Anke C Schiedel, et al.
Cancers|March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell LinesMartin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cell Death & Disease|October 14, 2016
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistanceYvonne Voges, Martin Michaelis, Florian Rothweiler, et al.
International Journal of Molecular Sciences|November 9, 2018
A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage FormationYunyun Luo, Yi He, Ditte Reker, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
International Journal for Parasitology|December 2, 2017
A cell culture platform for Cryptosporidium that enables long-term cultivation and new tools for the systematic investigation of its biologyChristopher N Miller, Lyne Jossé, Ian Brown, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Pageof 22